Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy

Asthma is a chronic inflammatory and multifactorial respiratory tract disease. It affects over 18 million adults and 6 million children in the USA with Puerto Ricans showing the highest prevalence (12%–19%). This airways illness can be triggered by an environmental stimulus such as grass pollen, fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocasio-Rivera, Marinel, Marin-Maldonado, Frances, Trossi-Torres, Geraline, Ortiz-Rosado, Angely, Rodríguez-Irizarry, Valerie, Rodriguez-Lopez, Eric, Martínez, Sahayra, Almodóvar, Sharilyn, Suarez-Martínez, Edu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581070/
https://www.ncbi.nlm.nih.gov/pubmed/33120736
http://dx.doi.org/10.1097/MD.0000000000022351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581070/
https://www.ncbi.nlm.nih.gov/pubmed/33120736
http://dx.doi.org/10.1097/MD.0000000000022351

Ejemplares similares